Reference
Valerio MR, et al. Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient. Acta Medica Mediterranea 36: 3041-3045, No. 5, 2020. Available from: URL: http://doi.org/10.19193/0393-6384_2020_5_468
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1833, 48 (2020). https://doi.org/10.1007/s40278-020-86866-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-86866-7